FHA
NVO

Flagship Harbor Advisors’s Novo Nordisk NVO Stock Holding History

Flagship Harbor Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
6,774
-781
-10% -$33.6K 0.01% 612
2026
Q1 		$278K Sell
7,555
-454
-6% -$21.5K 0.01% 614
2025
Q4 		$408K Sell
8,009
-1,678
-17% -$85.8K 0.02% 489
2025
Q3 		$538K Sell
9,687
-1,446
-13% -$84.6K 0.02% 477
2025
Q2 		$768K Sell
11,133
-3,002
-21% -$204K 0.04% 365
2025
Q1 		$982K Buy
14,135
+1,636
+13% +$135K 0.05% 280
2024
Q4 		$1.08M Sell
12,499
-584
-4% -$63.2K 0.06% 261
2024
Q3 		$1.56M Sell
13,083
-1,213
-8% -$162K 0.09% 211
2024
Q2 		$2.04M Buy
14,296
+1,845
+15% +$244K 0.12% 164
2024
Q1 		$1.6M Buy
12,451
+581
+5% +$69.2K 0.1% 185
2023
Q4 		$1.23M Buy
11,870
+593
+5% +$58.6K 0.09% 200
2023
Q3 		$1.03M Buy
11,277
+1,539
+16% +$136K 0.09% 213
2023
Q2 		$788K Buy
9,738
+2,602
+36% +$213K 0.07% 248
2023
Q1 		$568K Buy
7,136
+446
+7% +$31.6K 0.05% 326
2022
Q4 		$453K Sell
6,690
-414
-6% -$24.3K 0.05% 358
2022
Q3 		$354K Buy
7,104
+128
+2% +$6.86K 0.04% 389
2022
Q2 		$389K Buy
6,976
+118
+2% +$6.55K 0.04% 378
2022
Q1 		$381K Sell
6,858
-200
-3% -$10.3K 0.04% 421
2021
Q4 		$395K Buy
7,058
+2,046
+41% +$111K 0.04% 424
2021
Q3 		$210K Hold
5,012
– – 0.02% 600
2021
Q2 		$210K Buy
+5,012
New +$194K 0.02% 601
2020
Q4 		– Sell
-4,150
Closed -$144K – 1326
2020
Q3 		$144K Sell
4,150
-274
-6% -$9.13K 0.02% 549
2020
Q2 		$144K Buy
4,424
+2,838
+179% +$90.6K 0.02% 540
2020
Q1 		$48K Buy
1,586
+154
+11% +$4.58K 0.01% 763
2019
Q4 		$41K Buy
1,432
+2
+0.1% +$55 0.01% 882
2019
Q3 		$37K Buy
1,430
+8
+0.6% +$202 0.01% 881
2019
Q2 		$36K Sell
1,422
-248
-15% -$6.13K 0.01% 873
2019
Q1 		$43K Sell
1,670
-250
-13% -$6.14K 0.01% 802
2018
Q4 		$44K Sell
1,920
-1,094
-36% -$24.3K 0.01% 752
2018
Q3 		$70K Buy
3,014
+14
+0.5% +$342 0.01% 694
2018
Q2 		$69K Buy
+3,000
New +$71.3K 0.01% 691

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Flagship Harbor Advisors's NVO Position: Q2 2026 in Review

Flagship Harbor Advisors reduced its Novo Nordisk (NVO) stake by 10% in Q2 2026, selling an estimated $33.6K and leaving 6,774 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #612.

Flagship Harbor Advisors first reported a position in NVO in Q2 2018 and has held it in 31 quarters since. The position peaked at $2.04M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Flagship Harbor Advisors held 6,774 shares of Novo Nordisk worth $325K as of Q2 2026.
  • Flagship Harbor Advisors sold 781 Novo Nordisk shares in Q2 2026, an estimated $33.6K.
  • Novo Nordisk made up 0.01% of Flagship Harbor Advisors's portfolio in Q2 2026, its #612 holding.
  • Flagship Harbor Advisors first reported a position in Novo Nordisk in Q2 2018 and has held it in 31 quarters since.
  • Flagship Harbor Advisors's Novo Nordisk position peaked at $2.04M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.